ID: ALA199638

Max Phase: Preclinical

Molecular Formula: C14H13N3

Molecular Weight: 223.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1c[nH]c(CNc2ccc3ccccc3n2)c1

Standard InChI:  InChI=1S/C14H13N3/c1-2-6-13-11(4-1)7-8-14(17-13)16-10-12-5-3-9-15-12/h1-9,15H,10H2,(H,16,17)

Standard InChI Key:  PODSKRBRVVDCTK-UHFFFAOYSA-N

Associated Targets(Human)

Tyrosine-protein kinase TEC 1891 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 223.28Molecular Weight (Monoisotopic): 223.1109AlogP: 3.17#Rotatable Bonds: 3
Polar Surface Area: 40.71Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.91CX LogP: 2.92CX LogD: 2.91
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.72Np Likeness Score: -1.13

References

1. Inglis SR, Jones RK, Booker GW, Pyke SM..  (2006)  Synthesis of N-benzylated-2-aminoquinolines as ligands for the Tec SH3 domain.,  16  (2): [PMID:16260132] [10.1016/j.bmcl.2005.09.073]

Source